• Study on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany Italy Poland Spain
  • Study on Venetoclax, Cytarabine, and Mitoxantrone for Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML) Eligible for Intensive Treatment

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study Comparing Oral Paclitaxel (DHP107) and IV Paclitaxel for Patients with Recurrent or Metastatic HER2 Negative Breast Cancer

    Not recruiting

    4 1 1 1
    Investigated drugs:
    Hungary
  • Study on Digoxin for Reducing Heart Failure Hospitalizations and Mortality in Outpatients with Chronic Heart Failure

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness of Olaparib for Patients with Advanced Cancers and Specific Genetic Mutations

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Belgium
  • Study on the Effectiveness of Chemotherapy with Fluorouracil, Capecitabine, and Oxaliplatin for Patients with Small Bowel Adenocarcinoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on Pain Relief Using Botulinum Toxin in Thumb Osteoarthritis for Patients with Carpometacarpal Joint Issues

    Not recruiting

    2 1 1
    Investigated diseases:
    France
  • Study of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant

    Not recruiting

    2 1 1
    Investigated drugs:
    France
  • Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France

powered by